Xencor (XNCR) EBT Margin Growth (3y) (2016 - 2026)
Xencor (XNCR) EBT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Xencor |
953.38 Mn |
878.64 Mn |
- |
-254,336.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-254,336.00 |
| Dec 31, 2025 |
4,256.00 |
| Sep 30, 2025 |
8,731.00 |
| Jun 30, 2025 |
2,146.00 |
| Mar 31, 2025 |
-17,841.00 |
| Dec 31, 2024 |
-13,189.00 |
| Sep 30, 2024 |
-6,240.00 |
| Jun 30, 2024 |
-30,118.00 |
| Mar 31, 2024 |
-41,722.00 |
| Dec 31, 2023 |
792.00 |
| Sep 30, 2023 |
-557.00 |
| Jun 30, 2023 |
21,041.00 |
| Mar 31, 2023 |
-28,017.00 |
| Dec 31, 2022 |
71,594.00 |
| Sep 30, 2022 |
-6,742.00 |
| Jun 30, 2022 |
-1,068.00 |
| Mar 31, 2022 |
-4,136.00 |
| Dec 31, 2021 |
20,481.00 |
| Sep 30, 2021 |
-21,504.00 |
| Dec 31, 2020 |
-5,354.00 |
